Imidazoquinoline Compound (VAdv-Ly0028)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VAdv-Ly0028 |
|
Imidazoquinoline compound, a TLR7 agonist vaccine adjuvant.
Datasheet
Specifications
Type
PRRs Agonist
Formula
C17H23N5O▪HCl
Molecular Weight
349.9
Specificity
TLR7 agonist
Product Form
White solid
Endotoxin
Lower than 5 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year.
Adjuvant Information
Introduction
Imidazoquinoline compounds serve as potent Toll-like receptor 7 (TLR7) agonists and immune response modifiers, exhibiting significant anti-tumor properties. Research has demonstrated their ability to stimulate antigen-presenting cells, such as dendritic cells, and enhance the activation of T cells and natural killer cells. These characteristics make them promising candidates for use as vaccine adjuvants.
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
